Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
The International Journal of Artificial Organs|December 1, 1993
Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTPC Porta, E Bobbio-Pallavicini, R Centurioni, et al.
Expert Review of Anticancer Therapy|September 13, 2013
The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinomaF Stenner-Liewen, V Grünwald, R Greil, et al.
Archives of Virology|January 1, 1989
Limitations of different ELISA procedures for localizing epitopes in viral coat protein subunitsE L Dekker, C Porta, M H Van Regenmortel
International Journal of Cancer|December 15, 1979
An assay for estradiol preceptors using a staphylococcal protein-A--estradiol antibody adsorbentE Ronchi, C Porta, G Di Fronzo, et al.
Autonomic Neuroscience : Basic & Clinical|August 4, 2001
Modulatory effects of respirationL Bernardi, C Porta, A Gabutti, et al.
Oncology Reports|May 19, 2011
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patientsG Nastasi, C Porta, M Moroni, et al.
Anticancer Research|September 1, 1996
Antioxidant enzymatic system and free radicals pathway in two different human cancer cell linesC Porta, M Moroni, P Guallini, et al.
Histology and Histopathology|January 1, 1992
Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findingsL Gioglio, C Porta, M Moroni, et al.
Cancer Research|December 29, 1998
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomasC Ghigna, M Moroni, C Porta, et al.
Oncology Reports|May 21, 2011
Inadequacy of combined 5-Fluorouracil, very-high-dose leucovorin, mitomycin-C and Cisplatin as 2nd-line therapy for advanced colon-cancerG Nastasi, C Porta, M Moroni, et al.
Pageof 19